Compare ABEO & TLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABEO | TLS |
|---|---|---|
| Founded | 1974 | 1969 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 399.5M | 358.0M |
| IPO Year | 2005 | 2020 |
| Metric | ABEO | TLS |
|---|---|---|
| Price | $5.97 | $4.79 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $20.00 | $7.90 |
| AVG Volume (30 Days) | ★ 1.5M | 532.7K |
| Earning Date | 05-13-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 165.16 | 31.51 |
| EPS | N/A | ★ 0.03 |
| Revenue | $2,998,000.00 | ★ $164,805,000.00 |
| Revenue This Year | $1,024.31 | $18.72 |
| Revenue Next Year | $145.42 | $14.62 |
| P/E Ratio | ★ N/A | $163.50 |
| Revenue Growth | ★ 258.18 | 52.21 |
| 52 Week Low | $4.00 | $3.79 |
| 52 Week High | $7.65 | $8.36 |
| Indicator | ABEO | TLS |
|---|---|---|
| Relative Strength Index (RSI) | 41.86 | 60.00 |
| Support Level | $5.83 | $4.21 |
| Resistance Level | $5.97 | $4.95 |
| Average True Range (ATR) | 0.21 | 0.20 |
| MACD | -0.04 | 0.05 |
| Stochastic Oscillator | 34.68 | 74.14 |
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.
Telos Corp offers technology solutions and services that empower and protect the world's security-conscious organizations. The company delivers efficient, adaptable, and secure solutions that protect people, organizations, and information across government and industry. The company conducts its business through two reportable and operating segments: Security Solutions and Secure Networks. The Security Solutions segment is focused on cybersecurity, cloud, and identity solutions, and secure messaging through Xacta, Telos AMHS, and Telos ID offerings. The Secure Networks segment provides secure networking architectures and solutions to customers through secure mobility solutions, network management, and defense services. The majority of revenue is from Secure Networks.